ETIL
Live / Applied — Opposition pending (as of 12 Dec 2024)
What this means for you
Not registered yet, but its 19 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97761200
- Mark type
- Stylized text
- Filed
- 19 Jan 2023
- Published for opposition
- 13 Aug 2024
- Attorney of record
- CHRISTINA M. LICURSI
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals comprised of engineered cells for the treatment of cancer, infectious diseases, and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, renal, pulmonary, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system, inflammatory, and autoimmune related diseases and disorders
Owner
- KSQ Therapeutics, Inc., Lexington, MA, US
- KSQ Therapeutics, Inc., Lexington, MA, US
Prosecution history
- 12 Dec 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 12 Dec 2024 — OPPOSITION INSTITUTED NO. 999999
- 11 Sept 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 13 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Aug 2024 — PUBLISHED FOR OPPOSITION
- 24 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Apr 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Apr 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Jan 2024 — NON-FINAL ACTION E-MAILED
- 29 Jan 2024 — NON-FINAL ACTION WRITTEN
- 19 Dec 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Dec 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE